PULM
Pulmatrix Inc
NASDAQ: PULM · HEALTHCARE · BIOTECHNOLOGY
$1.26
+1.61% today
Updated 2026-04-30
Market cap
$4.67M
P/E ratio
—
P/S ratio
2,459.21x
EPS (TTM)
$-1.41
Dividend yield
—
52W range
$1 – $9
Volume
0.1M
Pulmatrix Inc (PULM) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-30000.00 | $-426000.00 | $-2.97M | $-2.97M | $-12.47M | $-13.24M | $-14.48M | $-16.76M | $3.23M | $-12.48M | $-19.73M | $-19.36M | $-15.98M | $-10.72M | $-5.43M |
| Capital expenditures | $0.00 | $4000.00 | $0.00 | $156000.00 | $266000.00 | $455000.00 | $74000.00 | $19000.00 | $58000.00 | $281000.00 | $144000.00 | $86000.00 | $676000.00 | $398000.00 | $0.00 |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | — | $444000.00 | — | $1.08M | $9.76M | $4.00M | $2.82M | $2.97M | $2.07M | $1.16M | $1.16M | $1.11M | $954000.00 | $511000.00 | $25000.00 |
| Free cash flow | $-30000.00 | $-430000.00 | $-2.97M | $-3.13M | $-12.74M | $-13.70M | $-14.55M | $-16.78M | $3.17M | $-12.76M | $-19.87M | $-19.44M | $-16.66M | $-11.11M | $-5.43M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | $0.00 | $0.00 | $0.00 | $0.00 | — | — | — | $3.20M | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | $-5.21M | $18.45M | $-14.72M | $-632000.00 | $-987000.00 | $20.88M | $8.22M | — | — | — | — | — |